Grundlæggende statistik
| CIK | 1615999 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Neuropathix Inc
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| October 20, 2023 |
UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION SECURITIES EXCHANGE ACT OF 1934 Release No. |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-55657 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 NEUROPATHIX, INC. |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-55657 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10- |
|
| April 15, 2022 |
DESCRIPTION OF SECURITIES The following is a summary of the material terms and provisions of the securities of Neuropathix, Inc. |
|
| April 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55657 NEUROPATHIX, INC. (Exact nam |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-55657 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form |
|
| March 25, 2022 |
Form of Convertible Note dated March 21, 2022. Exhibit 10.1 CONVERTIBLE NOTE $50,000 San Diego, California March 21, 2022 FOR VALUE RECEIVED, the undersigned, Neuropathix, Inc., a Delaware corporation (?Debtor?), promises to pay to the order of [INVESTOR], a [ ], or order (?Holder?), at the corporate offices of Holder, or such other place as Holder may designate in writing, the principal amount of Fifty Thousand and 00/100 Dollars ($50,000), t |
|
| March 25, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 21, 2022 NEUROPATHIX, INC. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 NEUROPATHIX, INC. |
|
| September 28, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): September 28, 2021 Neuropathix, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| September 28, 2021 |
Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS) Pharmaceutical Assets Include Company?s Non-Opioid Anti-inflammatory Compound KLS-13019 to Treat Chemotherapy Induced Peripheral Neuropathy (CIPN) Company?s Strategy is to Utilize the Phase 2 Study Grant Funds to Complete |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 NEUROPATHIX, INC. |
|
| June 23, 2021 |
As filed with the U.S. Securities and Exchange Commission on June 23, 2021. As filed with the U.S. Securities and Exchange Commission on June 23, 2021. Registration No. 333-248966 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEUROPATHIX, INC. (Exact name of registrant as specified in its charter) Delaware 7372 46-2645343 (State or Other Jurisdictio |
|
| May 13, 2021 |
10-Q 1 nptx033121form10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission |
|
| March 30, 2021 |
10-K 1 nptx123120form10k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000- |
|
| March 17, 2021 |
SECOND AMENDMENT TO KANNALIFE, INC. 2019 EQUITY INCENTIVE PLAN WHEREAS, the Board of Directors and stockholders of Neuropathix, Inc. (fka Kannalife, Inc.) (the “Company”) adopted the Kannalife, Inc. 2019 Equity Incentive Plan (as amended to date, the “Plan”) on August 14, 2019; WHEREAS, the Company amended its Articles of Incorporation on November 4, 2020 to change the Company’s name to Neuropathi |
|
| March 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 12, 2021 Neuropathix, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 23, 2021 |
Warrant No. 2, effective February 10, 2021 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE BEEN AND WILL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?) AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (ii) THE SALE OF SUCH SECURITIES IS MADE PURSUANT TO RULE 144 PROMULGATED UNDER THE ACT. |
|
| February 23, 2021 |
Warrant No. 1, effective February 10, 2021 EX-10.2 3 ex102.htm EXHIBIT 10.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE BEEN AND WILL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBST |
|
| February 23, 2021 |
Common Stock Purchase Agreement, dated February 17, 2020 NEUROPATHIX, INC. COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement (this ?Agreement?), dated as of February 17, 2021, but for all purposes shall be effective as of February 10, 2021 (the ?Effective Date?), is entered into by and between Neuropathix, Inc., a Delaware corporation (the ?Company?), and Lyons Capital LLC (the ?Investor?). RECITALS A. The Company desires to sell 3,50 |
|
| February 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): February 17, 2021 Neuropathix, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| December 21, 2020 |
Pharmaceutical Royalty Agreement, dated December 17, 2020 PHARMACEUTICAL ROYALTY AGREEMENT This Pharmaceutical Royalty Agreement dated as of December 17, 2020 (the “Royalty Agreement”) is made by and between Neuropathix, Inc. |
|
| December 21, 2020 |
Intellectual Property Rights Purchase and Transfer Agreement, dated December 17, 2020 EX-10.1 2 ex101.htm EXHIBIT 10.1 INTELLECTUAL PROPERTY RIGHTS PURCHASE AND TRANSFER AGREEMENT This Intellectual Property Rights Purchase and Transfer Agreement (this “IP Purchase Agreement” or “Agreement”) is effective this 17th day of December 2020, by and between Advanced Neural Dynamics, Inc. (“AND”) located at the Pennsylvania Biotechnology Center (“PBC”) at 3805 Old Easton Road, Doylestown, P |
|
| December 21, 2020 |
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate DOYLESTOWN, PA – December 21, 2020 – Neuropathix, Inc. (OTCQB: NPTX), (the “Company” or "Neuropathix"), a socially responsible pain management life sciences company, announced today that it acquired neuroprotective and anticonvulsant small-molecule drug technology from Advanced Neural Dynamics, Inc., (“AND”) |
|
| December 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): December 17, 2020 Neuropathix, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 19, 2020 |
Binding Letter of Intent, dated November 17, 2020 November 17, 2020 Advanced Neural Dynamics, Inc. 3805 Old Easton Road Doylestown, PA 18902 Attn: Douglas Brenneman, CEO Via email: [email protected] Fox Chase Chemical Diversity Center, Inc. 3805 Old Easton Road Doylestown, PA 18902 Attn: Allen Reitz, CEO Via email: [email protected] RE: Proposed Acquisition of Anticonvulsant IP Estate from Advanced Neural Dynamics, Inc. (“AND”) an |
|
| November 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 17, 2020 Neuropathix, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 19, 2020 |
EX-99.1 3 ex991.htm EXHIBIT 99.1 Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property DOYLESTOWN, PA – Nov. 19, 2020 – Neuropathix, Inc. (OTCQB: NPTX), formerly Kannalife, Inc. (the “Company” or "Neuropathix"), a socially responsible pain management life sciences company, announced today it has entered into a binding letter of intent to |
|
| November 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 NEUROPATHIX, INC. |
|
| November 6, 2020 |
EX-99.1 3 ex991.htm EXHIBIT 99.1 Kannalife, Inc. Rebrands as Neuropathix, Inc.; Reveals New Name, Ticker Symbol, Updated Logo and Visual Identity DOYLESTOWN, PA – Nov. 5, 2020 – Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development of potent novel monotherapeutics, announced today that the Company has chan |
|
| November 6, 2020 |
Certificate of Amendment, filed on November 4, 2020. CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KANNALIFE, INC. |
|
| November 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 4, 2020 Kannalife, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 30, 2020 |
Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 September 30, 2020 VIA EDGAR Division of Corporation Finance Office of Life Sciences U.S. Securities & Exchange Commission (the “Commission”) 100 F Street, N.E. Washington, D.C. 20549 Attention: Margaret Schwartz Re: Kannalife, Inc. Registration Statement on Form S-1 Filed September 22, 2020 File No. 333-248966 Ladies and Gentlemen: Pursuan |
|
| September 29, 2020 |
United States securities and exchange commission logo September 29, 2020 Dean Petkanas Chief Executive Officer Kannalife Inc 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife Inc Registration Statement on Form S-1 Filed September 22, 2020 File No. |
|
| September 29, 2020 |
United States securities and exchange commission logo September 29, 2020 Dean Petkanas Chief Executive Officer Kannalife Inc 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife Inc Registration Statement on Form S-1 Filed September 22, 2020 File No. |
|
| September 22, 2020 |
Power of Attorney (included on the signature page of the registration statement) As filed with the U.S. Securities and Exchange Commission on September 22, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (Exact name of registrant as specified in its charter) Delaware 7372 46-2645343 (State or Other Jurisdiction of Incorporation) (Primary Standard |
|
| September 22, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): September 18, 2020 Kannalife, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| September 22, 2020 |
Equity Purchase Agreement by and between the Company and Cross & Company, dated September 22, 2020. EQUITY PURCHASE AGREEMENT This equity purchase agreement is entered into as of September 18, 2020 (this "Agreement"), by and between Kannalife, Inc. |
|
| August 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 KANNALIFE, INC. |
|
| June 30, 2020 |
Form of Irrevocable Transfer Agent Letter. KANNALIFE, INC. June 19, 2020 Securities Transfer Corporation 2901 Dallas Parkway Plano, TX 75093 Re: Irrevocable Letter of Instruction Ladies and Gentlemen: Kannalife, Inc., a Delaware corporation (the “Company”) and (the “Investor”) have entered into a securities purchase agreement dated as of June 19, 2020 (the “Agreement”), providing for the issuance of the 12% promissory note in the principal |
|
| June 30, 2020 |
Form of Convertible Promissory Note. NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| June 30, 2020 |
Form of Securities Purchase Agreement. EX-10.1 2 ex101.htm EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 19, 2020, by and between KANNALIFE, INC., a Delaware corporation, with headquarters located at 3805 Old Easton Road, Doylestown, PA 18902 (the “Company”), and , with its address at (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering thi |
|
| June 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): June 23, 2020 Kannalife, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| June 30, 2020 |
EX-10.4 5 ex104.htm EXHIBIT 10.4 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUAN |
|
| June 11, 2020 |
Form of Convertible Promissory Note. NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| June 11, 2020 |
Form of Securities Purchase Agreement. SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 2, 2020, by and between KANNALIFE, INC. |
|
| June 11, 2020 |
NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION ST |
|
| June 11, 2020 |
Form of Irrevocable Transfer Agent Letter. KANNALIFE, INC. June 2, 2020 Securities Transfer Corporation 2901 Dallas Parkway, Suite 380 Plano, TX 75093 Re: Irrevocable Transfer Agent Instructions Ladies and Gentlemen: KANNALIFE, INC., a Delaware corporation (the "Company") and (the "Investor") have entered into a securities purchase agreement (the “Agreement”) on June 2, 2020, for the purchase and issuance of that certain 12% convertible pr |
|
| June 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): June 8, 2020 Kannalife, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 KANNALIFE, INC. |
|
| April 10, 2020 |
United States Securities And Exchange Commission Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 24, 2020 Bio-Matrix Scientific Group, Inc. |
|
| April 10, 2020 |
AGREEMENT AND PLAN OF MERGER by and among BIO-MATRIX SCIENTIFIC GROUP, INC., a Delaware corporation, RIVULET FILMS, INC., a Delaware corporation, and RIVULET FILMS LLC, an Arizona limited liability company Dated as of April 8, 2020 Article 1 DESCRIPTION OF TRANSACTION 1 1.1 MERGER OF MERGER SUB INTO THE COMPANY 1 1.2 EFFECT OF THE MERGER 1 1.3 CLOSING; EFFECTIVE TIME 1 1.4 CERTIFICATE OF INCORPORA |
|
| April 10, 2020 |
Rivulet Films Merges with Bio-Matrix Scientific Group, Inc. NEW Rivulet Media to Fund Film Productions Using Proprietary Financing Model April 9, 2020 - Gilbert, AZ - Rivulet Films’ Executives Aaron Klusman and Mike Witherill are announcing a merger with publicly traded Bio-Matrix Scientific Group, Inc. (“Bio-Matrix”) (ticker symbol BMSND), intending to rename Bio-Matrix as Rivulet Media. The comp |
|
| April 10, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits United States Securities And Exchange Commission Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 8, 2020 Bio-Matrix Scientific Group, Inc. |
|
| March 30, 2020 |
Form of Common Stock Purchase Warrant. NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| March 30, 2020 |
Kannalife, Inc. 2019 Equity Incentive Plan and related form agreements. KANNALIFE, Inc. 2019 EQUITY INCENTIVE PLAN Termination Date: August 14, 2029 1. General. (a) Purposes. The purposes of the Plan are as follows: (i) To provide additional incentive for selected Employees, Directors and Consultants to further the growth, development and financial success of the Company by providing a means by which such persons can personally benefit through the ownership of capital |
|
| March 30, 2020 |
KLFE / Kannalife, Inc. 10-K - Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55657 KANNALIFE, INC. (Exact name |
|
| March 30, 2020 |
Form of Junior Unsecured Convertible Note. NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATE |
|
| March 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 12, 2020 Kannalife, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| March 18, 2020 |
Form of Securities Purchase Agreement. SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 12, 2020, by and between KANNALIFE, INC. |
|
| March 18, 2020 |
Form of Irrevocable Transfer Agent Letter March 12, 2020 Securities Transfer Corporation 2901 N. Dallas Parkway, Suite 380 Plano, Texas 75093 Re: Irrevocable Transfer Agent Instructions Ladies and Gentlemen: Kannalife, Ind., a Delaware corporation (the "Company"), and (the “Investor”) have entered into a Securities Purchase Agreement dated as of March 12, 2020 (the “Agreement”) providing for the issuance of the Convertible Promissory Note |
|
| March 18, 2020 |
Form of Convertible Promissory Note. NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| January 28, 2020 |
January 28, 2020 Dear Kannalife Shareholders, Since our inception in 2010, Kannalife’s mission, as “a phyto-medical company” has been to advance the scientific and potential therapeutic value of cannabaceae constituents, including cannabinoid compounds like cannabidiol (CBD) found in cannabis and hemp and terpenophenolic compounds found in Humulus, better known as Hops. |
|
| January 28, 2020 |
Kannalife, Inc. CEO Recaps 2019 Advances and Potential Ahead Kannalife, Inc. CEO Recaps 2019 Advances and Potential Ahead DOYLESTOWN, PA – January 28, 2020 – Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, announced today that it has issued a letter to its shareholders providing commentary on the Company’s recent initiatives and corporate upda |
|
| January 28, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): January 28, 2020 Kannalife, Inc. (Exact name of Registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| November 13, 2019 |
KLFE / Kannalife, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 Kannalife, Inc. |
|
| August 14, 2019 |
KLFE / Kannalife, Inc. CT ORDER - - begin 644 filename1 M)5!$1BTQ+C8-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5AF4@,C4O5'EP92]84F5F+U=;,2 R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F * !(,?D""L1'$G04DV&R 1")(;(HB Q,CPTR0$@9&K,1QCV 0(, ,S" M!NH-"F5N9'-TL#*B M$8A9&#@:D,58H9B!H9%! *A3DF5WPMGF^U#E'[9 M;6!M3+\3X'P&=D! @P M8@T)/PT*96YD%LP(# @-C$R(## 9F6A3:^). |
|
| August 13, 2019 |
KLFE / Kannalife, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 Kannalife, Inc. |
|
| August 8, 2019 |
KLFE / Kannalife, Inc. S-1/A - - FORM S-1/A AMENDED REGISTRATION STATEMENT Form S-1/A Amended Registration Statement As filed with the U.S. Securities and Exchange Commission on August 8 , 2019. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 8 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 7372 46-2645343 |
|
| August 8, 2019 |
KLFE / Kannalife, Inc. CORRESP - - Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 August 8, 2019 VIA EDGAR Division of Corporation Finance U.S. Securities & Exchange Commission (the “Commission”) 100 F Street, N.E. Washington, D.C. 20549 Attention:Jeffrey Gabor Joe McCann Re:Kannalife, Inc. Registration Statement on Form S-1 File No. 333-227736 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, |
|
| August 7, 2019 |
August 7, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 7 to Registration Statement on Form S-1 Filed July 30, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information |
|
| August 7, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - August 7, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 7 to Registration Statement on Form S-1 Filed July 30, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information |
|
| July 30, 2019 |
KLFE / Kannalife, Inc. S-1/A - - FORM S-1/A AMENDED REGISTRATION STATEMENT Form S-1/A Amended Registration Statement As filed with the U.S. Securities and Exchange Commission on July 30 , 2019. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 7 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 7372 46-2645343 ( |
|
| July 30, 2019 |
KLFE / Kannalife, Inc. CORRESP - - SEC Response Letter PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. |
|
| July 23, 2019 |
July 23, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 6 to Registration Statement on Form S-1 Filed July 5, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information s |
|
| July 23, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - July 23, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 6 to Registration Statement on Form S-1 Filed July 5, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information s |
|
| July 5, 2019 |
KLFE / Kannalife, Inc. S-1/A - - FORM S-1/A AMENDED REGISTRATION STATEMENT S-1/A 1 s1a6070319s1z.htm FORM S-1/A AMENDED REGISTRATION STATEMENT As filed with the U.S. Securities and Exchange Commission on July 5, 2019. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (Exact Name of Registrant as Specified in its Charter) De |
|
| July 5, 2019 |
KLFE / Kannalife, Inc. CORRESP - - SEC Response Letter PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. |
|
| July 2, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - July 1, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 5 to Registration Statement on Form S-1 Filed June 17, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information s |
|
| July 2, 2019 |
July 1, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 5 to Registration Statement on Form S-1 Filed June 17, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information s |
|
| June 17, 2019 |
KLFE / Kannalife, Inc. S-1/A - - FORM S-1/A AMENDED REGISTRATION STATEMENT Form S-1/A Amended Registration Statement As filed with the U.S. Securities and Exchange Commission on June 17 , 2019. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 7372 46-2645343 ( |
|
| June 17, 2019 |
KLFE / Kannalife, Inc. CORRESP - - SEC Response Letter PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. |
|
| June 10, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - June 7, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed May 23, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so |
|
| June 10, 2019 |
June 7, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed May 23, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so |
|
| May 23, 2019 |
KLFE / Kannalife, Inc. S-1/A - - FORM S-1/A AMENDED REGISTRATION STATEMENT Form S-1/A Amended Registration Statement As filed with the U.S. Securities and Exchange Commission on May 23 , 2019. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 7372 46-2645343 (S |
|
| May 23, 2019 |
KLFE / Kannalife, Inc. CORRESP - - SEC Response Letter PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. |
|
| May 14, 2019 |
KLFE / Kannalife, Inc. 10-Q Quarterly Report FORM 10-Q QUARTERLY REPORT Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 Kannalife, Inc. |
|
| April 25, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - April 25, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed April 9, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information |
|
| April 25, 2019 |
April 25, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed April 9, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information |
|
| April 9, 2019 |
TYYG / TYG Solutions Corp. FORM S-1/A AMENDED REGISTRATION STATEMENT Form S-1/A Amended Registration Statement As filed with the U.S. Securities and Exchange Commission on April 9, 2019. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (formerly known as TYG Solutions Corp.) (Exact Name of Registrant as Specified in |
|
| April 9, 2019 |
KLFE / Kannalife, Inc. CORRESP - - CORRESP 1 filename1.htm PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. 858.720.6300 F. 619.235.0398 DEL MAR HEIGHTS LAS VEGAS PHOENIX SAN DIEGO SILICON VALLEY April 9, 2019 VIA EDGAR AND OVERNIGHT DELIVERY Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Re:Kannalife, Inc. Amendment No. 2 to Registration Statement on |
|
| April 9, 2019 |
KLFE / Kannalife, Inc. FORM 10K ANNUAL REPORT (Annual Report) Form 10K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 1, 2019 |
TYYG / TYG Solutions Corp. FORM NT 10-K NOTICE OF LATE ANNUAL FILING Form NT 10-K Notice of Late Annual Filing U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR For Period Ended: December 31, 2018 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Fo |
|
| March 27, 2019 |
March 26, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed March 8, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information |
|
| March 27, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - March 26, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed March 8, 2019 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information |
|
| March 22, 2019 |
February 15, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed December 28, 2018 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with info |
|
| March 22, 2019 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - February 15, 2019 Dean Petkanas Chief Executive Officer Kannalife, Inc. 3805 Old Easton Road Doylestown, PA 18902 Re: Kannalife, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed December 28, 2018 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with info |
|
| March 8, 2019 |
TYYG / TYG Solutions Corp. FORM S-1/A AMENDED REGISTRATION STATEMENT Form S-1/A Amended Registration Statement As filed with the U.S. Securities and Exchange Commission on March 8, 2019 . Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (formerly known as TYG Solutions Corp.) (Exact Name of Registrant as Specified in |
|
| March 8, 2019 |
Exhibit 10.13 Materials Transfer and Testing Agreement CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [ * * * ]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR P |
|
| March 8, 2019 |
KLFE / Kannalife, Inc. CORRESP - - SEC Response Letter PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. |
|
| December 28, 2018 |
Settlement Agreement by and between TYG Solutions Corp. and Medical Marijuana, Inc. Exhibit 10.8 Settlement Agreement by and between TYG Solutions Corp. and Medical Marijuana, Inc. SETTLEMENT AND MUTUAL RELEASE AGREEMENT This Settlement and Mutual Release Agreement (hereinafter "Agreement") is entered into and made effective as of July 15, 2017 (the "Effective Date") by and between Karmalife Sciences, Inc., a Delaware corporation ("KLSI") and Karma Botanicals, Inc., a Delaware co |
|
| December 28, 2018 |
Exhibit 10.11 Feasibility Study Quotation by and between Kannalife Sciences, Inc. and Catalent Pharma Solutions, LLC. Solution for Cannabidiol Softgel Feasibility VERSION: SPQ-KBO-1255.00 Prepared for Kannalife Sciences, Inc. William Kinney Chief Scientific Officer 3805 Old Easton Road, Doylestown, PA 18902 (516) 669-3219 [email protected] Provided by Catalent Pharma Solutions Louis Weiner Reg |
|
| December 28, 2018 |
Exhibit 21.1 Schedule of Subsidiaries Exhibit 21.1 Schedule of Subsidiaries Kannalife Sciences, Inc., a Delaware corporation |
|
| December 28, 2018 |
Exhibit 3.7 Amendment to Amended and Restated Certificate of Incorporation, as filed with the Delaware Secretary of State on November 9, 2018 |
|
| December 28, 2018 |
Stock Purchase Agreement by and between Cross & Co. and the Company. Exhibit 10.12 Stock Purchase Agreement by and between Cross & Co. and the Company |
|
| December 28, 2018 |
Exhibit 10.9 Patent License Agreement – Exclusive by and between the National Institutes of Health and Kannalife Sciences, Inc. PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT - EXCLUSIVE COVER PAGE For PHS internal use only: License Number: L-113-2012/0 License Application Number: A-276-2010 Serial Number(s) of Licensed Patent(s) or Patent Application(s): U. S. Patent 6,630,507, issued October 7, |
|
| December 28, 2018 |
TYYG / TYG Solutions Corp. FORM S-1A AMENDED REGISTRATION STATEMENT S-1/A 1 s1a1s1z.htm FORM S-1A AMENDED REGISTRATION STATEMENT As filed with the U.S. Securities and Exchange Commission on December 28 , 2018. Registration No. 333-227736 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KANNALIFE, INC. (formerly known as TYG Solutions Corp.) (Exact Name of Reg |
|
| December 28, 2018 |
Exhibit 10.10 Patent License Agreement – Nonexclusive by and between the National Institutes of Health and Kannalife Sciences, Inc. NATIONAL INSTITUTE OF HEALTH PATENT LICENSE AGREEMENT – NONEXCLUSIVE COVER PAGE For the NIH’s internal use only: License Number: L-302-2014/0 License Application Number: A-271-2014 Serial Number(s) of Licensed Patent(s) or Patent Application(s): U. S. Patent 6,630,507 |
|
| December 28, 2018 |
KLFE / Kannalife, Inc. CORRESP - - SEC Response Letter PROCOPIO 12544 High Bluff Drive Suite 400 San Diego, CA 92130 T. |
|
| November 14, 2018 |
TYYG / TYG Solutions Corp. FORM 10Q QUARTERLY REPORT (Quarterly Report) Form 10Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55657 Kannalife, Inc. |
|
| November 2, 2018 |
November 1, 2018 Dean Petkanas Chief Executive Officer TYG Solutions Corp. 3805 Old Easton Road Doylestown, PA 18902 Re: TYG Solutions Corp. Registration Statement on Form S-1 Filed October 5, 2018 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may bett |
|
| November 2, 2018 |
KLFE / Kannalife, Inc. TEXT-EXTRACT - - November 1, 2018 Dean Petkanas Chief Executive Officer TYG Solutions Corp. 3805 Old Easton Road Doylestown, PA 18902 Re: TYG Solutions Corp. Registration Statement on Form S-1 Filed October 5, 2018 File No. 333-227736 Dear Mr. Petkanas: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may bett |
|
| October 5, 2018 |
TYYG / TYG Solutions Corp. FORM S-1 REGISTRATION STATEMENT Form S-1 Registration Statement As filed with the U.S. Securities and Exchange Commission on October 5, 2018. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 7372 46-2645343 (State or Other Jurisdiction of |
|
| October 5, 2018 |
Exhibit 21.1 Schedule of Subsidiaries Exhibit 21.1 Schedule of Subsidiaries Kannalife Sciences, Inc. |
|
| October 5, 2018 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant Form 8-K Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): October 4, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Comm |
|
| October 5, 2018 |
4806 West Gandy Boulevardi Tampa, Florida 33611 i 813.440.6380 Exhibit 16.1 Auditor's Letter October 5, 2018 Office of the Chief Accountant Securities and Exchange Commission 460 Fifth Street N. W. Washington, DC 20549 Re: TYG Solutions Corp. Commission File Number 000-55657 Dear Sirs: We have received a copy of, and are in agreement with, the statements being made by TYG Solutions Corp. in Item 4.01 of its Form 8-K dated October 5, 2018 and captioned “Change |
|
| October 2, 2018 |
Exhibit 99.2 The unaudited financial statements of Kannalife as of June 30, 2018. KannaLife Sciences, Inc. FINANCIAL STATEMENTS (UNAUDITED) JUNE 30, 2018 KannaLife Sciences, Inc. TABLE OF CONTENTS Financial Statements (Unaudited) Balance Sheets - as of June 30, 2018 and December 31, 2017 3 Statements of Operations - for the six months ended June 30, 2018 and 2017 4 Statements of Cash Flows - for t |
|
| October 2, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Form 8-K/A Amended Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 2, 2018 |
Unaudited Pro Forma Financial Statements Exhibit 99.3 The unaudited pro forma combined consolidated statements of operations for the years ended December 31, 2017 and 2016, and the six months ended June 30, 2018, which give effect to the acquisition of Kannalife. Unaudited Pro Forma Financial Statements On July 25, 2018, Kannalife Sciences, Inc. (the "Company") entered into a Share Exchange Agreement with TYG Solutions Corp. ("TYYG"), a |
|
| October 2, 2018 |
Exhibit 99.1 The audited financial statements of Kannalife as of December 31, 2017 and 2016, and the independent registered public accounting firm’s report related thereto. KANNALIFE SCIENCES, INC. INDEX TO FINANCIAL STATEMENTS Annual Report for Fiscal Year Ended December 31, 2017 and 2016 Page Report of Independent Registered Public Accounting Firm 2 Balance Sheets 3 Statements of Operations 4 St |
|
| September 25, 2018 |
KLFE / Kannalife, Inc. / Medical Marijuana Inc - SCHEDULE 13D/A1 Activist Investment Schedule 13D/A1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) Stuart Titus 12255 Crosthwaite Circle Poway, CA 92064 858-859-7638 (Name, Address and Telephone Number |
|
| August 8, 2018 |
KLFE / Kannalife, Inc. / General Hemp LLC - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) John Huemoeller 3805 Old Easton Rd. Doylestown, Pennsylvania 18902 760-607-8268 (Name, Address and Telephone |
|
| August 8, 2018 |
KLFE / Kannalife, Inc. / Cross & Co - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) James R. Arabia 3805 Old Easton Rd. Doylestown, Pennsylvania 18902 760-607-826 (Name, Address and Telephone |
|
| August 8, 2018 |
KLFE / Kannalife, Inc. / Arabia James R - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) James R. Arabia 3805 Old Easton Rd. Doylestown, Pennsylvania 18902 760-607-826 (Name, Address and Telephone |
|
| August 7, 2018 |
KLFE / Kannalife, Inc. / Medical Marijuana Inc - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) Stuart Titus 12255 Crosthwaite Circle Poway, CA 92064 858-859-7638 (Name, Address and Telephone Number of Pe |
|
| August 7, 2018 |
KLFE / Kannalife, Inc. / Kikis Thomas Evangelos - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) Thomas Kikis 3805 Old Easton Doylestown, PA 18902 760-607-8268 (Name, Address and Telephone Number of Person |
|
| August 7, 2018 |
KLFE / Kannalife, Inc. / Petkanas Dean - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* TYG Solutions Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873147102 (CUSIP Number) Dean Petkanas 3805 Old Easton Doylestown, PA 18902 760-607-8268 (Name, Address and Telephone Number of Perso |
|
| July 31, 2018 |
Form 8K Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 25, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commiss |
|
| July 31, 2018 |
Executive Employment Agreement by and between TYG Solutions Corp. and Dean Petkanas Exhibit 10.4 Executive Employment Agreement, dated as of July 25, 2018, by and between TYG Solutions Corp. and Dean Petkanas. EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of July 25, 2018 (the “Effective Date”), is entered into by and between TYG Solutions Corp., a Delaware corporation (the “Company”), and Dean Petkanas (“Executive”). RECITALS WHE |
|
| July 31, 2018 |
Form of Lock-up Agreement (Kannalife Stockholders) Exhibit 10.1 Form of Lock-up Agreement (Kannalife Stockholders). LOCK-UP AND LEAK-OUT AND RELEASE AGREEMENT This Lock-Up and Leak-Out and Release Agreement (the "Agreement") is entered into by and between TYG Solutions, Corp., a Delaware corporation (the "Company"), Kannalife Sciences, Inc., a Delaware corporation ("Kannalife") and those Kannalife stockholders that have executed this Agreement, th |
|
| July 31, 2018 |
Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp. Exhibit 99.1 Press Release, dated as of July 31, 2018. Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp. July 31, 2018 – Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange transaction with TYG Solutions Corp. (OTC: TYYG). The closing of this transaction marks an important ste |
|
| July 31, 2018 |
Form of Lock-up Agreement (Dean Petkanas Block) Exhibit 10.3 Form of Lock-up Agreement (Petkanas Block). LOCK-UP AND LEAK-OUT AND RELEASE AGREEMENT This Lock-Up and Leak-Out and Release Agreement (the “Agreement”) is entered into by and between TYG Solutions, Corp., a Delaware corporation (the “Company”), Kannalife Sciences, Inc., a Delaware corporation (“Kannalife”) and those Kannalife stockholders that have executed this Agreement, the Share |
|
| July 31, 2018 |
Executive Employment Agreement by and between TYG Solutions Corp. and Mark Corrao Exhibit 10.6 Executive Employment Agreement, dated as of July 25, 2018, by and between TYG Solutions Corp. and Mark Corrao. EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of July 25, 2018 (the “Effective Date”), is entered into by and between TYG Solutions Corp., a Delaware corporation (the “Company”), and Mark Corrao (“Executive”). RECITALS WHEREAS |
|
| July 31, 2018 |
Executive Employment Agreement by and between TYG Solutions Corp. and William Kinney, PhD Exhibit 10.7 Executive Employment Agreement, dated as of July 25, 2018, by and between TYG Solutions Corp. and William Kinney, PhD. EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of July 25, 2018 (the “Effective Date”), is entered into by and between TYG Solutions Corp., a Delaware corporation (the “Company”), and William Kinney (“Executive”). RECIT |
|
| July 31, 2018 |
EX-2.1 2 f8k073118ex2z1.htm EXHIBIT 2.1 SHARE EXCHANGE AGREEMENT, DATED AS OF JULY 25, 2018 BY AND AMONG TYG SOLUTIONS CORP., KANNALIFE SCIENCES, INC. AND ITS STOCKHOLDERS. SHARE EXCHANGE AGREEMENT This Share Exchange Agreement, dated as of July 25, 2018 (this “Agreement”), is made and entered into by and among TYG Solutions Corporation, a Delaware corporation (“TYYG” or the “Company”) on the one |
|
| July 31, 2018 |
Executive Employment Agreement by and between TYG Solutions Corp. and Thomas Kikis Exhibit 10.5 Executive Employment Agreement, dated as of July 25, 2018, by and between TYG Solutions Corp. and Thomas Kikis. EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of July 25, 2018 (the “Effective Date”), is entered into by and between TYG Solutions Corp., a Delaware corporation (the “Company”), and Thomas Kikis(“Executive”). RECITALS WHEREA |
|
| July 31, 2018 |
Form of Lock-up Agreement (Management Stockholders) Exhibit 10.2 Form of Lock-up Agreement (Management Stockholders). LOCK-UP AND LEAK-OUT AND RELEASE AGREEMENT This Lock-Up and Leak-Out and Release Agreement (the “Agreement”) is entered into by and between TYG Solutions, Corp., a Delaware corporation (the “Company”), Kannalife Sciences, Inc., a Delaware corporation (“Kannalife”) and those Kannalife stockholders that have executed this Agreement, t |
|
| July 30, 2018 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities 8-K 1 f8k0730188k.htm FORM 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 24, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of |
|
| July 27, 2018 |
TYYG / TYG Solutions Corp. FORM 10Q/A AMENDED QUARTERLY REPORT (Quarterly Report) Form 10Q/A Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to |
|
| July 24, 2018 |
TYYG / TYG Solutions Corp. FORM 10K ANNUAL REPORT (Annual Report) Form 10K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 24, 2018 |
TYYG / TYG Solutions Corp. FORM 10Q QUARTERLY REPORT (Quarterly Report) Form 10Q Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO. 000-5565 |
|
| July 24, 2018 |
TYYG / TYG Solutions Corp. FORM 10Q QUARTERLY REPORT (Quarterly Report) Form 10Q Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO. 000-556 |
|
| July 24, 2018 |
Convertible Note Purchase Agreement dated February 16, 2018 Exhibit 4.1 Convertible Note Purchase Agreement |
|
| July 24, 2018 |
Convertible Note dated February 16, 2018 Exhibit 4.1 Convertible Note |
|
| May 25, 2018 |
Exhibit 3.2 Amended and Restated Certificate of Incorporation of TYG Solutions Corp., effective as of May 1, 2018. |
|
| May 25, 2018 |
Exhibit 3.5 Certificate of Designation of Series B Preferred Stock of TYG Solutions Corp. effective as of May 3, 2018 |
|
| May 25, 2018 |
Exhibit 3.3 Amended and Restated Bylaws of TYG Solutions Corp. effective as of May 2, 2018. |
|
| May 25, 2018 |
Form 8-K/A Amended Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 25, 2018 |
Exhibit 3.4 Certificate of Designation of Series A Preferred Stock of TYG Solutions Corp. effective as of May 3, 2018. |
|
| May 15, 2018 |
TYYG / TYG Solutions Corp. FORM NT 10-Q NOTICE OF LATE QUARTERLY FILING Form NT 10-Q Notice of Late Quarterly Filing SEC File Number: 000-55657 CUSIP Number: 873147102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 4, 2018 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Form 8-K Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 1, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commissi |
|
| May 4, 2018 |
Exhibit 3.4 Certificate of Designation of Series B Preferred Stock |
|
| May 4, 2018 |
Exhibit 3.3 Certificate of Designation of Series A Preferred Stock |
|
| May 4, 2018 |
Amended and Restated Bylaws of TYG Solution Corp. Exhibit 3.5 Amended and Restated Bylaws |
|
| May 4, 2018 |
Exhibit 3.2 Amended and Restated Certificate of Incorporation |
|
| April 25, 2018 |
Form 8K Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 23, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commis |
|
| April 18, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 12, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R. |
|
| April 18, 2018 |
Registered with the Public Company Accounting Oversight Board Exhibit 16.1 Letter from PLS CPA April 18, 2018 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-7561 Re: TYG Solutions Corp. Dear Madame or Sir On April 12, 2018 our appointment as auditor for TYG Solutions Corp., ceased. We have read TYG Solutions Corp.’s statement included under Item 4.01 of its Form 8-K dated April 18, 2018 and agree with such statements, insofar as the |
|
| March 30, 2018 |
TYYG / TYG Solutions Corp. FORM 12B-25 NOTICE OF LATE FILING Form 12b-25 Notice of Late Filing SEC File Number: 000-55657 CUSIP Number: 873147102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 9, 2018 |
SECURITIES AND EXCHANGE COMMISSION Exhibit 16.1 Letter from Weinberg & Baer, LLC Exhibit 16.1 SECURITIES AND EXCHANGE COMMISSION Division of Corporation Finance 100 F Street, N.E., Mail Stop 7010 Washington, D.C. 20549 Re:TYG Solutions, Inc. (the “Company”) Form 8-K Item 4.01, dated March 5, 2018 (the “Report”) Gentlemen: We have reviewed the above referenced Report filed by the Company. We agree with the statements made by the Com |
|
| March 9, 2018 |
Form 8K Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 5, 2018 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commiss |
|
| November 14, 2017 |
TYYG / TYG Solutions Corp. FORM 10Q QUARTERLY REPORT (Quarterly Report) Form 10Q Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO. 000 |
|
| August 18, 2017 |
TYYG / TYG Solutions Corp. FORM 10Q QUARTERLY REPORT (Quarterly Report) Form 10Q Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO. 000-5565 |
|
| August 14, 2017 |
TYG Solutions FORM NT 10Q NOTICE OF LATE QUARTERLY FILING NT 10-Q 1 nt10q063017nt10q.htm FORM NT 10Q NOTICE OF LATE QUARTERLY FILING SEC File Number: 000-55657 CUSIP Number: 873147102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR For Period Ended: June 30, 2017 [ ] Transition Report on Form 10 |
|
| June 20, 2017 |
TYG Solutions FORM 8K CURRENT REPORT (Current Report/Significant Event) Form 8K Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): June 20, 2017 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) Delaware 000-55657 46-2645343 (State or other jurisdiction of incorporation) (Commiss |
|
| May 22, 2017 |
TYG Solutions FORM 10Q QUARTERLY REPORT (Quarterly Report) 10-Q 1 f10q03311710q.htm FORM 10Q QUARTERLY REPORT U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMM |
|
| May 16, 2017 |
TYG Solutions FORM12B25 NOTICE OF LATE FILING Form12b25 Notice of Late Filing SEC File Number: 000-55657 CUSIP Number: 873147102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 30, 2017 |
BYLAWS OF TYG SOLUTIONS CORP. (a Delaware corporation) ARTICLE I STOCKHOLDERS 1. CERTIFICATES REPRESENTING STOCK. Certificates representing stock in the corporation shall be signed by, or in the name of, the corporation by the Chairperson or Vice-Chairperson of the Board of Directors, if any, or by the Chief Executive Officer or a Vice-Chief Executive Officer and by the Chief Financial Officer or |
|
| March 30, 2017 |
TYG Solutions 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [ x] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55657 TYG SOLUTIONS CORP. (Name |
|
| March 30, 2017 |
Certificate of Incorporation, as filed with the Delaware Secretary of State on March 25, 2013 We are pleased to confirm our understanding of the services we are to provide |
|
| November 21, 2016 |
TYG Solutions 10-Q (Quarterly Report) U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _ to _ COMMISSION FILE NO. 000-55657 TYG SOLUTIONS C |
|
| November 14, 2016 |
NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55657 NOTIFICATION OF LATE FILING CUSIP NUMBER 873147 102 (Check one): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended September 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 1 |
|
| August 29, 2016 |
KLFE / Kannalife, Inc. 10-Q - Quarterly Report - 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO. 000-55657 TYG SOLUTIONS CORP. (Exa |
|
| July 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 TYG SOLUTIONS CORP. (Exact name of registrant as specified in its charter) DELAWARE 46-2645343 (State of incorporation or organization) (I.R.S. Employer Identification No.) 202 Avenue F. Brooklyn, |
|
| July 11, 2016 |
July 11, 2016 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| June 22, 2016 |
TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 June 22, 2016 Mark P. Sherman Branch Chief United States Securities and Exchange Commission Washington, DC 20549 Re: TYG Solutions Corp. Amendment No. 9 to Registration Statement on Form S-1 Filed May 19, 2016 File No. 333-198284 Dear Mr. Sherman: In response to your letter of May 20, 2016, the Company has today filed Amendment No. 10 to the Reg |
|
| June 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of November 19, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| June 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of December 15, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| June 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of February 16, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| June 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of February 24, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| June 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT EX-10.1 4 exhibitex10z1.htm EXHIBIT 10.1 APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. Brooklyn NY, 11218 and Koso Technologies LTD (the “Company”) with an address at 154 Route 3 |
|
| June 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 20, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| June 22, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 10 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn |
|
| May 20, 2016 |
Mail Stop 4561 May 20, 2016 Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No. 9 to Registration Statement on Form S-1 Filed May 19, 2016 File No. 333-198284 Dear Mr. Barmatz: Our preliminary review of your registration statement indicates that it fails to include financial statements and related disclosures as necessary to comply wit |
|
| May 19, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 16, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| May 19, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of November 19, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| May 19, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of December 15, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| May 19, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 20, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| May 19, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 9 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| May 19, 2016 |
TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 May 19, 2016 Mark P. Sherman Branch Chief United States Securities and Exchange Commission Washington, DC 20549 Re: TYG Solutions Corp. Amendment No. 8 to Registration Statement on Form S-1 Filed May 5, 2016 File No. 333-198284 Dear Mr. Sherman: Risks Factors If We Are Not Able to Implement the Requirements of Section 404 of the Sarbanes-Oxley A |
|
| May 19, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| May 19, 2016 |
APPLICATION DEVELOPMENT AGREEMENT EX-10.4 7 exhibitex10z4.htm EXHIBIT 10.4 APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 24, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. Brooklyn NY, 11218 and Mobile NC (the “Company”) with an address at 160-10 89th St. Queens NY, 11432. RECITALS WHEREAS, the Company is eng |
|
| May 17, 2016 |
Mail Stop 4561 May 16, 2016 Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No. 8 to Registration Statement on Form S-1 Filed May 5, 2016 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your amended registration statement and have the following comments. Where indicated, we think you should revise your document in response to th |
|
| May 10, 2016 |
TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 May 10, 2016 Mark P. Sherman Branch Chief United States Securities and Exchange Commission Washington, DC 20549 Re: TYG Solutions Corp. Amendment No. 7 to Registration Statement on Form S-1 Filed April 13, 2016 File No. 333-198284 Dear Mr. Sherman: General Comment 1: We note your revisions in response to prior comment 1. Please also revise refer |
|
| May 5, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 8 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| May 5, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of November 19, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| May 5, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| May 5, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of December 15, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| May 5, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 24, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| May 5, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 16, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| May 5, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 20, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| April 27, 2016 |
Mail Stop 4561 April 27, 2016 Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No. 7 to Registration Statement on Form S-1 Filed April 13, 2016 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your amended registration statement and have the following comments. Where indicated, we think you should revise your document in response |
|
| April 13, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of December 15, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| April 13, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 7 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| April 13, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 20, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| April 13, 2016 |
TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 April 13, 2016 Mark P. Sherman Branch Chief United States Securities and Exchange Commission Washington, DC 20549 Re: TYG Solutions Corp. Amendment No. 6 to Registration Statement on Form S-1 Filed March 22, 2016 File No. 333-198284 Dear Mr. Sherman: General Comment 1.Throughout your filing, please revise references to your financial statements |
|
| April 13, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of February 24, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| April 13, 2016 |
APPLICATION DEVELOPMENT AGREEMENT EX-10.5 8 exhibitex10z5.htm EXHIBIT 10.5 APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of November 19, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. Brooklyn NY, 11218 and Gabriel Gold LTD (the “Company”) with an address at Freigutstrasse 24, 8002 Zürich, Switzerland. RECITALS WHEREAS, |
|
| April 13, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 16, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| April 13, 2016 |
APPLICATION DEVELOPMENT AGREEMENT EX-10.1 4 exhibitex10z1.htm EXHIBIT 10.1 APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. Brooklyn NY, 11218 and Koso Technologies LTD (the “Company”) with an address at 154 Route 3 |
|
| April 8, 2016 |
Mail Stop 4561 April 8, 2016 Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No 6. to Registration Statement on Form S-1 Filed March 22, 2016 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your amended registration statement and have the following comments. Where indicated, we think you should revise your document in response t |
|
| March 28, 2016 |
TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 March 28, 2016 Mark P. Sherman Branch Chief United States Securities and Exchange Commission Washington, DC 20549 Re: TYG Solutions Corp. Amendment No. 5 to Registration Statement on Form S-1 Filed October 23, 2015 File No. 333-198284 Dear Mr. Sherman: Prospectus Summary Overview, page 5 Comment 1. Please revise to describe the status of the agr |
|
| March 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of February 24, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| March 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 20, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| March 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of February 16, 2015, by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| March 22, 2016 |
S-1/A 1 tygs1s1z.htm S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 6 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification N |
|
| March 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| March 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of November 19, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| March 22, 2016 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of December 15, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| November 18, 2015 |
Mail Stop 4561 November 18, 2015 Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No 5. to Registration Statement on Form S-1 Filed October 23, 2015 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your amended registration statement and have the following comments. Where indicated, we think you should revise your document in resp |
|
| October 23, 2015 |
Converted by EDGARwiz S-1/A 1 tygs1s1z.htm S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 5 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classificatio |
|
| October 23, 2015 |
S-1/A 1 s1a5s1z.htm S-1/A S-1/A 1 tygs1s1z.htm S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 5 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classificat |
|
| October 23, 2015 |
TYG SOLUTIONS CORP. 202 Avenue F. Brooklyn, New York 11218 TYG SOLUTIONS CORP. 202 Avenue F. Brooklyn, New York 11218 October 22, 2015 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Attn: Mark P. Shuman Re: TYG Solutions Corp. Amendment No. 4 to Registration Statement on Form S-1 Filed February 11, 2015 File No. 333-198284 Dear Mr. Shuman: We are in receipt of your comment letter dated |
|
| October 23, 2015 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the ?Agreement?) is entered into as of February 16, 2015, by and between TYG Solutions Corp (the ?Developer?) with an address at 202 Ave F. |
|
| February 25, 2015 |
February 25, 2015 Via E-Mail Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No 4. to Registration Statement on Form S-1 Filed February 11, 2015 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your amended registration statement and have the following comments. Where indicated, we think you should revise your document in respons |
|
| February 11, 2015 |
KLFE / Kannalife, Inc. CORRESP - - TYG SOLUTIONS CORP. 202 Avenue F Brooklyn, New York 11218 February 11, 2015 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Attn: Mark P. Shuman Re: TYG Solutions Corp. Amendment No. 1 to Registration Statement on Form S-1 Filed December 15, 2014 File No. 333-198284 Dear Mr. Shuman: We are in receipt of your comment letter dated |
|
| February 11, 2015 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| February 11, 2015 |
KLFE / Kannalife, Inc. S-1/A - - S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| February 11, 2015 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| February 11, 2015 |
APPLICATION DEVELOPMENT AGREEMENT APPLICATION DEVELOPMENT AGREEMENT This Mobile Application Development Agreement (the “Agreement”) is entered into as of June 1, 2014, effective as of June 1, 2014 (the “Effective Date”) by and between TYG Solutions Corp (the “Developer”) with an address at 202 Ave F. |
|
| February 11, 2015 |
KLFE / Kannalife, Inc. S-1/A - - S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| February 11, 2015 |
KLFE / Kannalife, Inc. S-1/A - - S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| February 11, 2015 |
KLFE / Kannalife, Inc. CORRESP - - TYG SOLUTIONS CORP. 202 Avenue F Brooklyn, New York 11218 February 11, 2015 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Attn: Mark P. Shuman Re: TYG Solutions Corp. Amendment No. 1 to Registration Statement on Form S-1 Filed December 15, 2014 File No. 333-198284 Dear Mr. Shuman: We are in receipt of your comment letter dated |
|
| February 11, 2015 |
KLFE / Kannalife, Inc. CORRESP - - TYG SOLUTIONS CORP. 202 Avenue F Brooklyn, New York 11218 February 11, 2015 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Attn: Mark P. Shuman Re: TYG Solutions Corp. Amendment No. 1 to Registration Statement on Form S-1 Filed December 15, 2014 File No. 333-198284 Dear Mr. Shuman: We are in receipt of your comment letter dated |
|
| January 9, 2015 |
January 9, 2015 Via E-Mail Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Amendment No 1. to Registration Statement on Form S-1 Filed December 15, 2014 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your amended registration statement and have the following comments. Where indicated, we think you should revise your document in response |
|
| December 15, 2014 |
KLFE / Kannalife, Inc. S-1/A - - S-1/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment Number 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, |
|
| December 15, 2014 | ||
| December 15, 2014 |
KLFE / Kannalife, Inc. CORRESP - - TYG SOLUTIONS CORP. 202 Avenue F. Brooklyn, New York 11218 December 15, 2014 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Attn: Mark P. Shuman Re: TYG Solutions Corp. Registration Statement on Form S-1 Filed August 21, 2014 File No. 333-198284 Dear Mr. Shuman: We are in receipt of your comment letter dated September 17, 2014 |
|
| September 17, 2014 |
September 17, 2014 Via E-Mail Natan Barmatz President TYG Solutions Corp. 202 Avenue F. Brooklyn, NY 11218 Re: TYG Solutions Corp. Registration Statement on Form S-1 Filed August 21, 2014 File No. 333-198284 Dear Mr. Barmatz: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understa |
|
| August 21, 2014 |
BYLAWS OF TYG SOLUTIONS CORP. (a Delaware corporation) ARTICLE I STOCKHOLDERS 1. CERTIFICATES REPRESENTING STOCK. Certificates representing stock in the corporation shall be signed by, or in the name of, the corporation by the Chairperson or Vice-Chairperson of the Board of Directors, if any, or by the Chief Executive Officer or a Vice-Chief Executive Officer and by the Chief Financial Officer or |
|
| August 21, 2014 | ||
| August 21, 2014 |
KLFE / Kannalife, Inc. S-1 - Registration Statement - S-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TYG Solutions Corp. (Exact Name of Registrant in its Charter) Delaware 7374 46-2645343 (State or other Jurisdiction (Primary Standard Industrial (IRS Employer of Incorporation) Classification Code) Identification No.) 202 Avenue F. Brooklyn, New York 11218 (718)- |
